Results 161 to 170 of about 42,402 (225)

Investigating the In Vivo Effects of Anti-Prion Protein Nanobodies on Prion Disease with AAV Vector. [PDF]

Pathogens
Zhang J, Wang M, Wang D, Zhang X, Ma Y, Pardon E, Steyaert J, Abskharon R, Wang F, Ma J.   +9 more
europepmc   +1 more source

Author Correction: In vivo base editing extends lifespan of a humanized mouse model of prion disease. [PDF]

Nat Med
An M, Davis JR, Levy JM, Serack FE, Harvey JW, Brauer PP, Pirtle CP, Berríos KN, Newby GA, Yeh WH, Kamath N, Mortberg M, Lian Y, Howard M, DeSouza-Lenz K, Guzman K, Thai A, Graffam S, Laversenne V, Coffey AA, Frei J, Pierce SE, Safar JG, Deverman BE, Minikel EV, Vallabh SM, Liu DR.   +26 more
europepmc   +1 more source

Supportive care or exhausted neglect: the role of microglia at the end stage of prion disease. [PDF]

J Clin Invest
Lawson VA.
europepmc   +1 more source

Expression of Concern: Snord 3A: A Molecular Marker and Modulator of Prion Disease Progression. [PDF]

PLoS One
PLOS ONE Editors.
europepmc   +1 more source

Delayed progression of prion disease in mice by polyarginine-facilitated prevention of PrP^Sc propagation in the spleen. [PDF]

Neurotherapeutics
Lee S, Kim J, Lee Y, Yoo M, Kim J, Sohn HJ, Ryou C.   +6 more
europepmc   +1 more source

TREM2 supports neuronal protection and microglial reactivity without an effect on misfolded protein deposition in chronic neurodegenerative prion disease. [PDF]

Front Neurosci
Carpanini SM, Bradford BM, Alfieri A, Piccardo P, Monzón-Sandoval J, Brown D, Boyle A, Pokrovskaya A, Mabbott NA, Manson J, McColl BW.   +10 more
europepmc   +1 more source

Inherited Prion Disease with a 5-octapeptide Repeat Insertion in the PRNP Gene Presenting with Familial Juvenile Dementia. [PDF]

Intern Med
Nishikawa M, Takeda A, Miyazawa N, Hara N, Ishii K, Ikeuchi T, Itoh Y.   +6 more
europepmc   +1 more source

In situ assessment of neuroinflammatory cytokines in different stages of ovine natural prion disease. [PDF]

Front Vet Sci
Guijarro IM, Garcés M, Badiola JJ, Monzón M.   +3 more
europepmc   +1 more source

GPI-anchorless prion disease is sensitive to oxidative stress and shows potential for treatment with edaravone, based on iPS-derived neuron study. [PDF]

Cell Mol Life Sci
Matsuzono K, Honda H, Mashiko T, Koide R, Sakashita E, Endo H, Kitamoto T, Fujimoto S.   +7 more
europepmc   +1 more source